• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibody-drug conjugates: smart weapons against cancer.

作者信息

Hayat Seyed Mohammad Gheibi, Sahebkar Amirhossein

机构信息

Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran.

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Arch Med Sci. 2019 Feb 18;16(5):1257-1262. doi: 10.5114/aoms.2019.83020. eCollection 2020.

DOI:10.5114/aoms.2019.83020
PMID:32864020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7444717/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/8383a3c32094/AMS-16-5-35864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/8d6ad5251f13/AMS-16-5-35864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/78233b3ec6b0/AMS-16-5-35864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/8383a3c32094/AMS-16-5-35864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/8d6ad5251f13/AMS-16-5-35864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/78233b3ec6b0/AMS-16-5-35864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/7444717/8383a3c32094/AMS-16-5-35864-g003.jpg

相似文献

1
Antibody-drug conjugates: smart weapons against cancer.抗体药物偶联物：对抗癌症的智能武器。
Arch Med Sci. 2019 Feb 18;16(5):1257-1262. doi: 10.5114/aoms.2019.83020. eCollection 2020.
2
Antibody-drug therapeutic conjugates: Potential of antibody-siRNAs in cancer therapy.抗体药物偶联物：抗体-siRNA 在癌症治疗中的潜力。
J Cell Physiol. 2019 Aug;234(10):16724-16738. doi: 10.1002/jcp.28490. Epub 2019 Mar 25.
3
Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.用于癌症治疗的药物-单克隆抗体偶联物：潜力与局限
Crit Rev Ther Drug Carrier Syst. 1988;5(3):189-227.
4
Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer.抗体药物偶联物在上皮性卵巢癌治疗中的应用
Hematol Oncol Clin North Am. 2018 Dec;32(6):1057-1071. doi: 10.1016/j.hoc.2018.07.014. Epub 2018 Oct 1.
5
Safety and Tolerability of Antibody-Drug Conjugates in Cancer.抗体药物偶联物在癌症中的安全性和耐受性。
Drug Saf. 2019 Feb;42(2):295-314. doi: 10.1007/s40264-018-0775-7.
6
Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy.优化抗体药物偶联物在癌症治疗中成功构建的挑战
Antibodies (Basel). 2018 Feb 13;7(1):11. doi: 10.3390/antib7010011.
7
Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment.用于乳腺癌治疗的抗体药物偶联物的最新进展
Curr Med Chem. 2017;24(23):2505-2527. doi: 10.2174/0929867324666170530092350.
8
3D Printing Evarything: Products, Weapons, Also: Gravity; Flex Screens for Smart Phones, Keys, Lots of Data, An Ode in Praise of Knobs.
Binocul Vis Strabolog Q Simms Romano. 2013;28(4):248-56.
9
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.抗体药物偶联物：药代动力学/药效动力学建模、临床前特征描述、临床研究及经验教训。
Clin Pharmacokinet. 2018 Jun;57(6):687-703. doi: 10.1007/s40262-017-0619-0.
10
Statistics of the distribution of the abundance of molecules with various drug loads in maytansinoid antibody-drug conjugates.美登素抗体药物偶联物中具有不同药物负载量的分子丰度分布统计。
Mol Pharm. 2015 Jun 1;12(6):1738-44. doi: 10.1021/mp5007536. Epub 2015 Feb 17.

引用本文的文献

1
Antibody-Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections.抗体-抗生素偶联物：对抗细菌性感染的治疗潜力的全面综述。
J Clin Lab Anal. 2024 May;38(10):e25071. doi: 10.1002/jcla.25071. Epub 2024 Jun 13.
2
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.用于治疗肺癌的药物偶联物：从药物发现到临床实践
Exp Hematol Oncol. 2024 Mar 1;13(1):26. doi: 10.1186/s40164-024-00493-8.
3
Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids.

本文引用的文献

1
Antibody-drug conjugates: recent advances in conjugation and linker chemistries.抗体偶联药物：偶联和连接子化学的最新进展。
Protein Cell. 2018 Jan;9(1):33-46. doi: 10.1007/s13238-016-0323-0. Epub 2016 Oct 14.
2
Antibody drug conjugates: lessons from 20 years of clinical experience.抗体药物偶联物：20 年临床经验的教训。
Ann Oncol. 2016 Dec;27(12):2168-2172. doi: 10.1093/annonc/mdw424. Epub 2016 Oct 11.
3
Quantitative characterization of in vitro bystander effect of antibody-drug conjugates.定量表征抗体药物偶联物的体外旁观者效应。
利用硫酯连接的美登素类化合物的小分子药物偶联物的合成与评价
Pharmaceutics. 2022 Jun 21;14(7):1316. doi: 10.3390/pharmaceutics14071316.
4
Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates.用于二吡啶甲胺锌基药物缀合物连接基多样化的点击化学和多组分反应
Front Chem. 2022 Feb 15;9:822587. doi: 10.3389/fchem.2021.822587. eCollection 2021.
5
Recent advances of antibody drug conjugates for clinical applications.抗体药物偶联物在临床应用中的最新进展。
Acta Pharm Sin B. 2020 Sep;10(9):1589-1600. doi: 10.1016/j.apsb.2020.04.012. Epub 2020 Apr 24.
J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):567-582. doi: 10.1007/s10928-016-9495-8. Epub 2016 Sep 26.
4
Antibody-drug conjugates: Current status and future perspectives.抗体药物偶联物：现状与展望。
Pharmacol Ther. 2016 Nov;167:48-59. doi: 10.1016/j.pharmthera.2016.07.012. Epub 2016 Aug 2.
5
Antibody-drug conjugates for cancer therapy.用于癌症治疗的抗体药物偶联物。
Lancet Oncol. 2016 Jun;17(6):e254-e262. doi: 10.1016/S1470-2045(16)30030-4.
6
Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity.新型抗人表皮生长因子受体2抗体药物偶联物DS-8201a在具有人表皮生长因子受体2异质性的肿瘤中的旁观者杀伤效应
Cancer Sci. 2016 Jul;107(7):1039-46. doi: 10.1111/cas.12966. Epub 2016 Jun 22.
7
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates.抗体、药物和连接子对抗体药物偶联物临床前和临床毒性的影响。
MAbs. 2016 May-Jun;8(4):659-71. doi: 10.1080/19420862.2016.1156829. Epub 2016 Apr 5.
8
Antibody-drug conjugates--an emerging class of cancer treatment.抗体药物偶联物——一类新兴的癌症治疗药物。
Br J Cancer. 2016 Feb 16;114(4):362-7. doi: 10.1038/bjc.2015.435. Epub 2016 Jan 7.
9
Antibody Drug Conjugates for Cancer Therapy.抗体药物偶联物在癌症治疗中的应用。
Pharmacol Rev. 2016 Jan;68(1):3-19. doi: 10.1124/pr.114.009373.
10
Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates.抗体药物偶联物的内化、转运、细胞内加工及作用
Pharm Res. 2015 Nov;32(11):3577-83. doi: 10.1007/s11095-015-1729-8. Epub 2015 Jun 25.